“Laboratory assessment of liver function in people starting antiretroviral therapy with Dolutegravir or Efavirenz: a cohort study in Belo Horizonte, Brazil” (2022) Research, Society and Development, 11(13), p. e74111335082. doi:10.33448/rsd-v11i13.35082.